Breast – Invasive carcinoma of no special type (NST) showing strong MSH2 immunostaining in cancer cells.
Breast - Invasive carcinoma of no special type (NST) showing strong MSH2 immunostaining in cancer cells. 
Breast – Invasive lobular breast cancer with strong MSH2 immunostaining in cancer cells. Stromal cells and adjacent normal glands also show strong MSH2 positivity.
Breast - Invasive lobular breast cancer with strong MSH2 immunostaining in cancer cells. Stromal cells and adjacent normal glands also show strong MSH2 positivity. 
Colon – Colorectal adenocarcinoma showing a markedly reduced MSH2 immunostaining in cancer cells as compared to stromal and inflammatory cells
Colon - Colorectal adenocarcinoma showing a markedly reduced MSH2 immunostaining in cancer cells as compared to stromal and inflammatory cells. 
Colon – Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Colon - Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Colon – Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Colon - Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells. 
Colon – Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Colon - Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Colon – Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Colon - Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Colon – Colorectal adenocarcinoma with strong MSH2 immunostaining in stromal and inflammatory cells but absent MSH2 staining in cancer cells.
Colon - Colorectal adenocarcinoma with strong MSH2 immunostaining in stromal and inflammatory cells but absent MSH2 staining in cancer cells. 
Esophagus – Squamous cell carcinoma exhibiting a strong MSH2 immunostaining in cancer cells and in stromal cells.
Esophagus - Squamous cell carcinoma exhibiting a strong MSH2 immunostaining in cancer cells and in stromal cells. 
Ovary – Clear cell carcinoma showing strong MSH2 positivity in cancer cells and in stromal cells.
Ovary - Clear cell carcinoma showing strong MSH2 positivity in cancer cells and in stromal cells. 
Ovary – Malignant Mixed Mullerian tumor with strong MSH2 positivity in cancer cells and in stromal cells.
Ovary - Malignant Mixed Mullerian tumor with strong MSH2 positivity in cancer cells and in stromal cells. 
Ovary – Malignant Mixed Mullerian tumor with strong MSH2 positivity in stromal and inflammatory cells but absence of staining in tumor cells.
Ovary - Malignant Mixed Mullerian tumor with strong MSH2 positivity in stromal and inflammatory cells but absence of staining in tumor cells. 
Ovary – Serous high-grade carcinoma with strong MSH2 positivity in cancer cells and in stromal cells.
Ovary - Serous high-grade carcinoma with strong MSH2 positivity in cancer cells and in stromal cells. 
Pancreas – Adenocarcinoma of the ampulla Vaterii showing a strong MSH2 immunostaining in cancer cells and in stromal cells.
Pancreas - Adenocarcinoma of the ampulla Vaterii showing a strong MSH2 immunostaining in cancer cells and in stromal cells. 
Pancreas – Ductal adenocarcinoma (perineural tumor growth) with strong MSH2 immunostaining in cancer cells and in stromal cells.
Pancreas - Ductal adenocarcinoma (perineural tumor growth) with strong MSH2 immunostaining in cancer cells and in stromal cells. 
Pancreas – Ductal adenocarcinoma showing strong MSH2 immunostaining in cancer cells and in stromal cells.
Pancreas - Ductal adenocarcinoma showing strong MSH2 immunostaining in cancer cells and in stromal cells. 
Pancreas – Ductal adenocarcinoma with strong MSH2 positivity in cancer cells and in stromal cells.
Pancreas - Ductal adenocarcinoma with strong MSH2 positivity in cancer cells and in stromal cells. 
Prostate – Adenocarcinoma (Gleason 3+3=6) with strong MSH2 immunostaining in cancer cells and in stromal cells.
Prostate - Adenocarcinoma (Gleason 3+3=6) with strong MSH2 immunostaining in cancer cells and in stromal cells. 
Stomach – Gastric adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Stomach - Gastric adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.